Edwards Lifesciences: Strong Execution, But Little Room For Error At $90 (NYSE:EW)
· seekingalpha.com
Edwards Lifesciences is rated Sell with a $77 price target, reflecting limited upside versus the recent $89.72 close. Click for my latest analysis of EW stock.
Management of Edwards Lifesciences ( EW ) is doing a nice job—sales grew 13.6% in the second quarter; the company's full-year forecasts also got upgraded, and...